| Literature DB >> 23960236 |
Yingting Mok1, Vera Schwierzeck1, David C Thomas1, Elena Vigorito2, Tim F Rayner1, Lorna B Jarvis1, Haydn M Prosser3, Allan Bradley3, David R Withers4, Inga-Lill Mårtensson1, Lynn M Corcoran5, Cherie Blenkiron6, Eric A Miska6, Paul A Lyons1, Kenneth G C Smith1.
Abstract
MicroRNAs (MiRs) are small, noncoding RNAs that regulate gene expression posttranscriptionally. In this study, we show that MiR-210 is induced by Oct-2, a key transcriptional mediator of B cell activation. Germline deletion of MiR-210 results in the development of autoantibodies from 5 mo of age. Overexpression of MiR-210 in vivo resulted in cell autonomous expansion of the B1 lineage and impaired fitness of B2 cells. Mice overexpressing MiR-210 exhibited impaired class-switched Ab responses, a finding confirmed in wild-type B cells transfected with a MiR-210 mimic. In vitro studies demonstrated defects in cellular proliferation and cell cycle entry, which were consistent with the transcriptomic analysis demonstrating downregulation of genes involved in cellular proliferation and B cell activation. These findings indicate that Oct-2 induction of MiR-210 provides a novel inhibitory mechanism for the control of B cells and autoantibody production.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23960236 PMCID: PMC4162006 DOI: 10.4049/jimmunol.1301289
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422